Merriman Curhan Ford Acted As Placement Agent In GenVec's $28 Million Registered Offering
SAN FRANCISCO, Feb. 1 /PRNewswire-FirstCall/ -- Merriman Curhan Ford (Nasdaq: MERR) acted as a placement agent in GenVec, Inc.'s (Nasdaq: GNVC) $28 million registered offering of 14 million shares of common stock, and warrants to purchase 4.2 million shares of common stock, to certain institutional investors. The transaction closed today.
"We have been working with the Merriman team for several years and appreciate their continued efforts in advising GenVec on its financing activities," said Douglas Swirsky, Chief Financial Officer of GenVec.
The pricing of the offering was announced on January 27, 2010 by GenVec. Details on the transaction can be found at GenVec's Web site: www.genvec.com.A bout G e n V ec GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade™, is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. In addition, GenVec uses its proprietary adenovector technology to develop vaccines for infectious diseases including influenza, HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. GenVec also discovers and develops novel treatments for hearing loss and balance disorders through a worldwide collaboration with Novartis. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission. Ab o u t M e rr i man Cu r h an F o rd Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology. For more information, please go to www.mcfco.com. N ote t o I n v es t ors T his p re s s r e le a se c o nt a ins cer t ain for w a rd - lo o king s t a te m e n ts b a sed o n our cu r r e nt e x pe c ta t io n s, f o re c as t s a nd assu m p t io n s t h at inv o l v e r i sks a n d un c er t ai n t i es. T h is re l ease does not con s t i t u te an o f fer to s e l l or a s o l i c i t a tion of o f f ers to buy any sec u r i t i es o f t h e C o m pany. F or w a rd - loo k i n g st a te m e n ts in th i s r e le a se are b a sed on i n for m a ti o n a va i lab l e to us as of the da t e he r eo f . O ur a ctu a l r e su l ts m a y d i f f er m a t eri a l l y f rom t h ose st a ted or i m p l ied in s u ch f or w ar d - l o oking st a te m e n ts, d u e t o r i sks and unce r t a in t ies ass o ci a ted w i th our bu s ine s s, w h ich in cl ude t h e r isk fa c to r s d i s c lo s ed in o ur F orm 10- K /A f i l ed on A p r i l 30, 2009 a nd o u r F orm 1 0 -Q f i led on N o v e m ber 1 6, 2 009. F or w a r d - loo k ing st a t e m ents in c lude st a te m e n ts reg a rd i ng our e xp e ct a ti o ns, b e l ie fs , in t en t io n s or st r at e gi e s r e gard i ng t h e f ut u re and can be i d en t i f ied by f o r w ar d -lo o ki n g w ords s uch as "a n ti c ip a te , " " be l i ev e," " co u ld," " e s t i m at e ," "e x pect , " " i n tend , " " m ay," "s h ould , " " w i l l," and " w o u ld" or s i m i lar w o r ds. W e assu m e no o b l iga t i o n to u p da t e t h e i n for m a t i on in c luded in th i s p r ess r e le a se, w h e ther as a r e su l t o f new in f or m a ti on, f u tu r e e v en t s or o th e r w i se. T he F orm 1 0 - K /A f i led on A pr i l 30, 2009 a nd F o r m 10-Q f il e d on N ove m b e r 16, 2 009, to g eth e r w i th t his pr e ss r e l ea s e and t he fin a nc i al in f or m a tion co n tai n ed h er e in, is a v ail a ble on our w eb s i t e by goi n g to w w w . m cfco. c om and c l i c k ing o n "I n ve s tor R el a t i ons . " SOURCE Merriman Curhan Ford
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.